Neurological illness following treatment with fludarabine
| Autor: | T. A. Lister, J. Goldin, P. Domizio, K. Nagendran, A. Z. S. Rohatiner, J. Fearnley, J. Gawler, Peter Johnson |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
Adult
Male Drug Cancer Research medicine.medical_specialty media_common.quotation_subject Antineoplastic Agents Internal medicine medicine Humans In patient Vidarabine Aged media_common Dose-Response Relationship Drug business.industry Lymphoma Non-Hodgkin Middle Aged Fludarabine Oncology Lymphoid malignancy Immunology Female Nervous System Diseases business After treatment Research Article medicine.drug |
| Zdroj: | British Journal of Cancer |
| ISSN: | 1532-1827 0007-0920 |
| Popis: | Fludarabine is a comparatively new drug for the treatment of low-grade lymphoid malignancy. This report describes five cases of unusual neurological illnesses occurring after treatment with fludarabine. These suggest that caution should be exercised in patients receiving fludarabine who develop neurological abnormalities, with prompt investigation and if necessary cessation of the drug. Images Figure 1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|